Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2023-12-31 |
2023-01-01 to 2023-12-31 |
As at 2022-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification | — |
Transgene
|
— |
| Domicile of entity | — |
France
|
— |
| Legal form of entity | — |
Société anonyme
|
— |
| Address of entity's registered office | — |
400, boulevard Gonthier d’Andernach – Parc d’Innovation
|
— |
| Principal place of business | — |
L’établissement principal de la Société est localisé dans une
|
— |
| Name of parent entity | — |
TSGH
|
— |
| Name of ultimate parent of group | — |
Compagnie Mérieux Alliance
|
— |
| Statement of IFRS compliance [text block] | — |
Préambule
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current trade receivables |
778,000
EUR
|
— |
2 789
EUR
|